XTL Biopharmaceuticals Ltd - ADR

FRA:H2K2 (Israel)   ADR
€ 1.33 (0%) Dec 20
N/A
P/B:
3.50
Market Cap:
€ 7.25M ($ 7.56M)
Enterprise V:
€ 5.00M ($ 5.21M)
Volume:
-
Avg Vol (2M):
200.00
Trade In:

XTL Biopharmaceuticals Ltd Valuation Measures